Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 9;12(2):245.
doi: 10.3390/jpm12020245.

Optimizing Treatment of Parkinson's Disease

Dag Nyholm  1 , Filip Bergquist  2
Affiliations
Editorial

Optimizing Treatment of Parkinson's Disease

Dag Nyholm et al. J Pers Med. .

Abstract

The holy grail of therapy in Parkinson's disease (PD) is treatment that would halt the disease process or restore the degenerated neuronal circuits [...].

PubMed Disclaimer

Conflict of interest statement

Dag Nyholm has previously served as a consultant to AbbVie and Sensidose. He currently serves as a consultant to Britannia, NeuroDerm, NordicInfu Care and Stada and has received lecture fees from AbbVie. Filip Bergquist received in-kind support and advisory board fees from Global Kinetics and has been the national coordinator for a phase I trial of subcutaneous levodopa infusion (Dizlin AB) and is an investigator in a study sponsored by AbbVie. None of these parties had any influence on the design or analysis of the current editorial.

References

    1. Kilinçalp G., Sjöström A.-C., Eriksson B., Holmberg B., Constantinescu R., Bergquist F. Predictive value of ambulatory objective movement measurement for outcomes of levodopa/carbidopa intestinal gel infusion. J. Pers. Med. 2022;12:27. doi: 10.3390/jpm12010027. - DOI - PMC - PubMed
    1. Grétarsdóttir H.M., Widman E., Johansson A., Nyholm D. Personalized Medicine Approach in Treating Parkinson’s Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice. J. Pers. Med. 2021;11:720. doi: 10.3390/jpm11080720. - DOI - PMC - PubMed
    1. Sundgren M., Andréasson M., Svenningsson P., Noori R.-M., Johansson A. Does Information from the Parkinson KinetiGraphTM (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease. J. Pers. Med. 2021;11:519. doi: 10.3390/jpm11060519. - DOI - PMC - PubMed
    1. Henriksen T., Staines H. Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation. J. Pers. Med. 2021;11:525. doi: 10.3390/jpm11060525. - DOI - PMC - PubMed
    1. Van Poppelen D., Tromp A.N.M., de Bie R.M.A., Dijk J.M. Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease. J. Pers. Med. 2021;11:547. doi: 10.3390/jpm11060547. - DOI - PMC - PubMed

Publication types

LinkOut - more resources